AR and ovarian carcinoma: Besides testing the newly synthesised compounds on A2780 (ovarian carcinoma) and MCF-7 (breast adenocarcinoma, expressing the oestrogen, progesterone, and androgen receptors), an additional cell line, the triple-negative breast carcinoma MDA-MB-231, was also included in our study.